| 000 | 01352 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513042124.0 | ||
| 264 | 0 | _c19950602 | |
| 008 | 199506s 0 0 eng d | ||
| 022 | _a0361-8609 | ||
| 024 | 7 |
_a10.1002/ajh.2830490114 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCastaman, G | |
| 245 | 0 | 0 |
_aCharacterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor. _h[electronic resource] |
| 260 |
_bAmerican journal of hematology _cMay 1995 |
||
| 300 |
_a83-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aBleeding Time |
| 650 | 0 | 4 |
_aCiprofloxacin _xadverse effects |
| 650 | 0 | 4 |
_aCollagen _xmetabolism |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMacromolecular Substances |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_avon Willebrand Diseases _xblood |
| 650 | 0 | 4 |
_avon Willebrand Factor _xisolation & purification |
| 700 | 1 | _aLattuada, A | |
| 700 | 1 | _aMannucci, P M | |
| 700 | 1 | _aRodeghiero, F | |
| 773 | 0 |
_tAmerican journal of hematology _gvol. 49 _gno. 1 _gp. 83-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/ajh.2830490114 _zAvailable from publisher's website |
| 999 |
_c7740512 _d7740512 |
||